首页 > IVF > Factors Affecting IVF Success Rate for Male Factor in Thailand: Evaluation and Improvement Methods

Factors Affecting IVF Success Rate for Male Factor in Thailand: Evaluation and Improvement Methods

The success rate of IVF for male factor in Thailand is influenced by sperm quality, female age, embryo culture technology, and more. Through ICSI, PGT screening, and other techniques, male infertility can be treated specifically in Thailand. This article analyzes the real factors affecting success rates from a medical perspective, helping patients rationally assess their own situation.

Opening: Real Consultation Scenario

▍ Clinic Note — A 35-year-old man, after completing a semen analysis at a fertility center in Thailand, found his sperm concentration to be only 4.2 million/ml, motility 10%, and normal morphology rate 0.8%. He read the report twice, looked up, and asked, "Given my situation, what are my chances with IVF?"

How Semen Analysis Parameters Affect IVF Outcomes

Semen analysis is the foundation for evaluating male fertility and a key basis for determining the IVF treatment plan in Thailand. The normal reference ranges according to the World Health Organization (WHO 6th edition) are as follows:

Sperm Concentration ≥16 million/ml
Below this value indicates oligozoospermia
Total Motility (PR+NP) ≥42%
Below this value indicates asthenozoospermia
Progressive Motility (PR) ≥30%
Directly influences ICSI choice
Normal Morphology Rate ≥4%
Below 4% indicates teratozoospermia

It is important to clarify: Abnormal semen parameters do not mean IVF is impossible, but rather determine which technical path to take. Fertility centers in Thailand commonly use ICSI (Intracytoplasmic Sperm Injection) technology, which requires only one sperm with relatively normal morphology and motility to achieve fertilization. Therefore, even in cases of severe oligoasthenoteratozoospermia, as long as sperm can be obtained from the ejaculate or testicles, fertilization is possible.

However, one parameter is often overlooked — Sperm DNA Fragmentation Index (DFI). DFI reflects the integrity of sperm nuclear DNA. When DFI is above 30%, even if morphology and motility are normal, embryo implantation and blastocyst formation rates can significantly decrease. In some Thai laboratories, DFI testing has become a routine part of male factor assessment.

What Determines the Success Rate of IVF for Male Factor in Thailand

The success rate of IVF for male factor in Thailand is not a fixed number but is determined by the following variables:

  • Sperm Retrieval Status — Whether sufficient usable sperm are present in the ejaculate, or if surgical sperm retrieval (testicular biopsy, micro-TESE) is needed.
  • Female Age — This is the independent and strongest factor affecting IVF outcomes. When the female partner is ≤35 years old, the embryo euploidy rate is higher, and pregnancy rates are significantly better than in women over 40.
  • Embryo Culture and Screening Capability — Whether the laboratory can culture fertilized eggs to the blastocyst stage and whether it has PGT (Preimplantation Genetic Testing) capabilities directly impact transfer efficiency and pregnancy outcomes.
  • Sperm DNA Integrity — Men with lower DFI have better embryo developmental potential.

Based on clinical data (from treatment data of several Thai fertility centers between 2022-2024):
When the female partner is <35 years old, the male partner undergoes ICSI fertilization, and a euploid blastocyst is transferred, the ongoing pregnancy rate per single transfer is approximately 50%-65%.
When the female partner is over 40 years old, even if the male partner's sperm parameters are normal, the pregnancy rate drops below 20%. Therefore, "the success rate of IVF for male factor" must be evaluated within the context of the female partner's age.

Specific Process of IVF for Male Factor in Thailand

In Thailand, the IVF process for male factor differs slightly from conventional IVF, mainly in the sperm retrieval and handling stages:

Stage Key Steps Male-Specific Considerations
1. Evaluation & Preparation Semen analysis, sperm DNA fragmentation index, karyotype, Y-chromosome microdeletion Abstain for 2-5 days; if azoospermia, arrange surgical sperm retrieval evaluation in advance
2. Ovarian Stimulation & Egg Retrieval Female partner undergoes ovarian stimulation; sperm retrieval on egg retrieval day If sperm quality is very poor, consider freezing sperm before egg retrieval day
3. ICSI Fertilization Embryologist selects sperm with the best morphology and motility to inject into the egg Severe teratozoospermia may require IMSI (high-magnification sperm selection)
4. Embryo Culture & PGT Culture to blastocyst (day 5-6), biopsy for chromosomal screening Embryos from male factor have a slightly higher chance of chromosomal abnormalities than female factor
5. Transfer & Luteal Support Transfer of euploid blastocyst; pregnancy test 12-14 days after transfer No special treatment needed; follow medication instructions

The entire cycle from the start of ovarian stimulation to the end of transfer usually takes 4-6 weeks. If a frozen embryo transfer (with prior PGT screening) is chosen, the cycle extends to 2-3 months.

Easily Overlooked Details

① Sperm DNA Fragmentation Index (DFI)

Many patients only focus on sperm concentration, motility, and morphology, ignoring DFI. Men with high DFI, even if ICSI fertilization is successful, may experience embryo developmental arrest, biochemical pregnancy, or early miscarriage after transfer. Some Thai laboratories have included DFI as a routine test, costing approximately 2000-4000 THB. When DFI > 30%, it is recommended to undergo antioxidant therapy or lifestyle intervention for 3-6 months before starting the cycle.

② Karyotype & Y-Chromosome Microdeletion

Among patients with severe oligozoospermia or azoospermia, the detection rate of Y-chromosome microdeletion (AZF deletion) is about 10%-15%. These patients have limited sperm production capacity, and if offspring are conceived via ICSI, male children will carry the same deletion. Thai law allows screening for sex-related genetic issues during PGT, but this needs to be discussed with the embryologist in advance.

③ Timing of Sperm Retrieval

For patients with fluctuating sperm quality, the sperm status on the day of egg retrieval may be completely different from the initial diagnosis. It is recommended to reassess sperm quality 1-2 days before egg retrieval and, if necessary, freeze sperm in advance for ICSI use.

Practitioner Observation: In Thailand, about 12% of male factor patients have suboptimal sperm quality on the day of egg retrieval, requiring a temporary switch to frozen sperm or surgical sperm retrieval. Having a plan in place can prevent cycle cancellation.

Frequently Asked Questions

Q1: Is the success rate high for azoospermia patients undergoing IVF in Thailand?

Azoospermia is divided into obstructive and non-obstructive types. For obstructive azoospermia (e.g., vas deferens blockage), the success rate of obtaining sperm via testicular biopsy or micro-TESE exceeds 90%, and the ICSI fertilization rate is not significantly different from using ejaculated sperm. For non-obstructive azoospermia (spermatogenic dysfunction), the sperm retrieval success rate is about 40%-60%. Once sperm is obtained, the subsequent process is the same as conventional ICSI. Female age remains the key factor determining pregnancy rate.

Q2: Can I still do IVF if my sperm abnormality rate is 99%?

Yes. Teratozoospermia does not affect the fertilization rate in ICSI because the embryologist selects sperm with relatively normal morphology under high magnification. However, severe abnormalities (such as globozoospermia, acephaly) may be linked to genetic mutations, and genetic counseling is recommended.

Q3: Do men need to optimize their health before IVF in Thailand? How long does it take?

The sperm production cycle is about 72-90 days, so it is recommended to optimize for at least 3 months before starting the cycle. Specific measures include: avoiding high-temperature environments (saunas, hot springs), quitting smoking and alcohol, and supplementing with antioxidants like L-carnitine, Coenzyme Q10, zinc, and selenium. For patients with high DFI, rechecking DFI after optimization to confirm a decrease before starting the cycle can significantly improve embryo quality.

Doctor's Perspective: Decision Logic for Male Factor IVF

From a reproductive doctor's perspective, the core issue in male factor IVF is not "whether it can be done," but "which protocol to use." The decision pathway is as follows:

  • Step 1: Confirm sperm source. Are there sperm in the ejaculate? If not, can sperm be obtained surgically? If surgery also fails to retrieve sperm, consider donor sperm or adoption.
  • Step 2: Assess female ovarian reserve. Regardless of male sperm quality, the female's age, AMH, and antral follicle count determine how many eggs can be obtained, thus affecting embryo quantity and screening opportunities.
  • Step 3: Choose technical protocol. Acceptable sperm quality → conventional ICSI; severe teratozoospermia or high DFI → consider IMSI or DFI screening followed by optimization; genetic risk → add PGT.
  • Step 4: Embryo transfer strategy. Embryos from male factor have a slightly higher rate of chromosomal abnormalities. PGT-A screening is recommended to select euploid embryos for transfer, which can increase the pregnancy rate per single transfer and reduce miscarriage risk.

A reproductive doctor in Thailand once summarized: "The success of male factor IVF depends half on the sperm and half on the egg. What we can do is maximize the potential of the sperm, but we cannot change the biological age of the egg. So, don't just focus on the sperm report; the female evaluation is equally important."

Common Pitfalls

Myth 1: Poor sperm quality means IVF is impossible

This is the most common misconception. In reality, ICSI technology was designed for male factor. As long as there is one usable sperm, fertilization is possible. Many fertility centers in Thailand have extensive experience in handling male factor, including micro-TESE, IMSI, and sperm freezing.

Myth 2: Only focusing on the male, ignoring female age

Some male patients think, "Once my sperm problem is solved, IVF will succeed." However, clinical data shows that after a woman's age exceeds 38, the egg aneuploidy rate rises sharply. Even with the best quality sperm, the embryo euploidy rate is less than 40%. Therefore, male factor patients choosing IVF in Thailand must simultaneously evaluate the female partner's fertility condition.

Myth 3: Blindly choosing low-cost stimulation protocols

IVF costs in Thailand vary significantly depending on the protocol and medication brands. Male factor patients typically require ICSI, and some may need IMSI or PGT, which incur additional costs. Choosing a low-cost package that does not include these techniques may lead to poor cycle outcomes. It is recommended to confirm before signing a contract whether the fee covers ICSI, embryo culture to blastocyst, and PGT screening (if needed).

Myth 4: Neglecting sperm freezing backup

If the male partner has difficulty producing a sample on egg retrieval day or sperm quality suddenly declines, it directly impacts the ICSI procedure. Freezing a sperm sample in advance as a backup can prevent cycle cancellation or rescheduling. In Thailand, sperm freezing costs approximately 5000-10000 THB per year, which is very cost-effective.

Reasons Behind Male Factor

The causes of decreased male fertility are complex. Common categories include:

  • Genetic factors: Y-chromosome microdeletion, chromosomal translocations, cystic fibrosis gene mutations, etc.
  • Endocrine factors: Hypogonadotropic hypogonadism, hyperprolactinemia, thyroid dysfunction, etc.
  • Anatomical/Obstructive factors: Congenital absence of the vas deferens, epididymal obstruction, varicocele, etc.
  • Lifestyle and Environment: Long-term exposure to high temperatures, smoking, alcohol abuse, obesity, contact with chemical toxins or radiation, etc.
  • Idiopathic: About 30%-40% of male factor patients have no identifiable cause, classified as idiopathic spermatogenic failure.

The significance of identifying the cause is that some causes can be treated to improve sperm quality (e.g., varicocele surgery, endocrine therapy), potentially avoiding IVF or improving its success rate. Therefore, it is recommended that male patients complete etiological screening in their home country before traveling to Thailand and bring complete test reports for the consultation in Thailand.

▍ Risk Reminder

① All assisted reproductive technologies carry certain risks, including but not limited to: ovarian hyperstimulation syndrome, complications from egg retrieval surgery, no usable embryos, biochemical pregnancy or miscarriage after transfer, multiple pregnancies, etc.

② Offspring of male factor patients conceived via ICSI have a slightly higher probability of chromosomal abnormalities or genetic defects compared to naturally conceived populations. PGT screening before embryo transfer and prenatal diagnosis in the second trimester are recommended.

③ Medical tourism in Thailand involves cross-border medical care. Patients must bear the inconveniences and risks related to language communication, medical dispute resolution, and follow-up care. It is recommended to choose a正规, JCI-accredited fertility center and sign a detailed medical informed consent form.

④ The success rate data mentioned in this article are statistical results from specific populations at some Thai fertility centers and do not constitute a promise or guarantee of any individual treatment outcome. Please refer to the evaluation of the attending physician for specific circumstances.

Medical Editor · Reproductive Medicine Knowledge Base | Content Review: Physician certified by the Thai Reproductive Medicine Committee

References: WHO Laboratory Manual for the Examination and Processing of Human Semen, 6th ed.; ESHRE Guidelines for Male Infertility; Clinical data compilation from Thai fertility centers

在线咨询
ONLINE CONSULTATION
泰国代孕网在线咨询二维码-免费获取试管婴儿方案
扫码加客服免费得
4000600670